FRA
ARNA

Front Row Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Front Row Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-24
Closed -$2K – 1046
2020
Q2 		$2K Hold
24
– – ﹤0.01% 895
2020
Q1 		$1K Buy
+24
New +$1.1K ﹤0.01% 948

Other funds holding ARNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Front Row Advisors's ARNA Position: Q3 2020 in Review

Front Row Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2020, closing a stake of 24 shares — an estimated $2K sold.

Front Row Advisors first reported a position in ARNA in Q1 2020 and held it in 2 quarters. The position peaked at $2K in Q2 2020. 253 funds tracked by Wall St. Rank hold ARNA as of Q3 2020.

  • Front Row Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q3 2020 after selling out during the quarter.
  • Front Row Advisors sold 24 Arena Pharmaceuticals Inc shares in Q3 2020, an estimated $2K.
  • Front Row Advisors first reported a position in Arena Pharmaceuticals Inc in Q1 2020 and held it in 2 quarters.
  • Front Row Advisors's Arena Pharmaceuticals Inc position peaked at $2K in Q2 2020.
  • 253 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2020.

Based on Front Row Advisors's 13F filing for Q3 2020, filed 30 Nov 2020.